Medtronic Asks FCC To Move Forward on Revised Experimental License Rules
Medtronic officials asked the FCC to move forward on new rules that would make medical device manufacturers eligible for medical testing experimental licenses, one of the areas examined in a July Further NPRM (see 1507080050). Medtronic emphasized that the current…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
rules also “preclude operation in the MedRadio band of 401-406 MHz thereby preventing medical device companies from conducting research under a program experimental license on new devices that would operate in the band.” The FCC should move forward with revised rules “so that the promise of the Program Experimental License rules may come to fruition,” the company said. The filing was made in docket 10-236.